(Q36134783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

main subject

phase II clinical trial

0 references

author

Elisabeth de Vries

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

J M Stouthard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H Goey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P H de Mulder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

A Groenewegen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

L Pronk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

G Stoter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H P Sauerwein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P J Bakker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

C H Veenhof

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

789-793

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.1996.137

15 October 2019

exact match

0 references

cites work

Cytotoxic chemotherapy for advanced renal cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

How large should a phase II trial of a new drug be?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Molecular regulation of B lymphocyte response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Antitumor activity of recombinant interleukin 6 in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Growth regulatory functions of IL6 and antitumour effects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

IL6 and the acute phase reaction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

IL6 and thrombocytopoiesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

IL6 and the T-cell response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Interleukin-6 in renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Interleukin-6 and renal cell cancer: production, regulation, and growth effects

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074380

Endocrinologic and metabolic effects of interleukin-6 in humans

2 July 2018

1 reference

12 December 2020

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

1 reference

12 December 2020

Interferon-gamma interrupts autocrine growth mediated by endogenous interleukin-6 in renal-cell carcinoma

1 reference

12 December 2020

Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator

1 reference

12 December 2020

Immunotherapy for metastatic renal cell carcinoma

1 reference

12 December 2020

Interleukin-6 and TNF alpha production in human renal cell carcinoma

1 reference

12 December 2020

Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans

1 reference

12 December 2020

Tumour stimulating effects of recombinant human interleukin-6

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8611381%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

PubMed publication ID

8611381

1 reference